STERIS PLC Reports Financial Results for First Quarter of FY2024

August 25, 2023

🌥️Earnings Overview

On August 1 2023, STERIS PLC ($NYSE:STE) reported its financial results for the first quarter of FY2024, which ended on June 30 2023. The total revenue generated for this quarter was USD 1284.5 million, a year-on-year increase of 11.1%. Net income also rose by 11.0%, reaching USD 123.6 million.

Price History

At the opening bell, STERIS PLC stock was priced at $223.8, and ended the day at $224.0, a slight decline of 0.7% from its prior closing price of $225.6. These results come on the heels of STERIS PLC’s strong performance over the past year and represent a positive start to fiscal year 2024. With its strong financial results and promising outlook, STERIS PLC is well-positioned to continue delivering value for its shareholders for years to come. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Steris Plc. More…

    Total Revenues Net Income Net Margin
    5.09k 119.32 8.7%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Steris Plc. More…

    Operations Investing Financing
    806.33 -340.51 -570.94
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Steris Plc. More…

    Total Assets Total Liabilities Book Value Per Share
    10.78k 4.61k 61.6
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Steris Plc are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    19.2% 13.5% 5.9%
    FCF Margin ROE ROA
    9.7% 3.1% 1.7%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we have done an analysis of STERIS PLC‘s wellbeing to help potential investors make an informed decision. According to our Risk Rating, STERIS PLC is a medium risk investment in terms of financial and business aspects. We have detected two risk warnings in their income statement and balance sheet, so if you’re interested to know more, please register with us. We will provide an in-depth look at the company and its performance to help you decide whether to invest or not. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    The company’s main competitors are Fonar Corp, Stryker Corp, and Dynatronics Corp.

    – Fonar Corp ($NASDAQ:FONR)

    Fonar Corporation is a holding company, which engages in the design, manufacture, sale, and service of magnetic resonance imaging (MRI) scanners. It operates through the following segments: Upright Multi-Position MRI; Stand-Up MRI; and Recurring Revenue. The Upright Multi-Position MRI segment designs, manufactures, and sells Upright Multi-Position MRI scanners. The Stand-Up MRI segment designs, manufactures, sells, and services Stand-Up MRI scanners. The Recurring Revenue segment provides service contracts, technical support, and parts sales. The company was founded by Stanley C. Krulick in 1978 and is headquartered in Melville, NY.

    – Stryker Corp ($NYSE:SYK)

    Stryker Corporation is one of the world’s leading medical technology companies. It offers a wide range of medical devices and services, including orthopedics, neurotechnology, and medical imaging. It has more than 87,000 employees worldwide.

    – Dynatronics Corp ($NASDAQ:DYNT)

    Dynatronics Corp is a medical device company that manufactures and markets physical therapy products and solutions. The company’s products are used by physical therapists, occupational therapists, athletic trainers, and other healthcare professionals. Dynatronics Corp has a market cap of 8.73M as of 2022, a Return on Equity of -10.7%. The company’s products are sold in the United States and internationally.


    STERIS PLC‘s financial performance for the first quarter of FY2024 has been strong. Total revenue grew 11.1%, to USD 1284.5 million, while net income rose 11.0%, to USD 123.6 million. These results reflect the company’s ability to increase sales and manage expenses.

    The outlook for STERIS PLC remains positive, with further growth expected in the coming quarters. Investors should consider this stock for its strong earnings potential and solid financial position.

    Recent Posts

    Leave a Comment